Publications
Flagella as a platform for epitope-based vaccines.
Ben-Yedidia T, Arnon R.
Isr Med Assoc J. 2006 May;8(5):316-8.
Towards an epitope-based human vaccine for influenza.
Ben-Yedidia T, Arnon R.
Hum Vaccin. 2005 May-Jun;1(3):95-101. Epub 2005 May 15.
Old and new vaccine approaches.
Arnon R, Ben-Yedidia T. Int Immunopharmacol. 2003 Aug; 3(8):1195-204.
Peptide-based synthetic recombinant vaccines with anti-viral efficacy.
Arnon R, Tarrab-Hazdai R, Ben-Yedidia T. Biologicals. 2001 Sep-Dec;29(3-4):237-42.
Intranasal administration of synthetic recombinant peptide-based vaccine protects mice from infection by Schistosoma mansoni.
Ben-Yedidia T, Tarrab-Hazdai R, Schechtman D, Arnon R. Infect Immun. 1999 Sep;67(9):4360-6.
Intranasal administration of peptide vaccine protects human/mouse radiation chimera from influenza infection.
Ben-Yedidia T, Marcus H, Reisner Y, Arnon R. Int Immunol. 1999 Jul;11(7):1043-51.
Effect of pre-existing carrier immunity on the efficacy of synthetic influenza vaccine.
Ben-Yedidia T, Arnon R. Immunol Lett. 1998 Nov;64(1):9-15.
Efficacy of anti-influenza peptide vaccine in aged mice.
Ben-Yedidia T, Abel L, Arnon R, Globerson A. Mech Ageing Dev. 1998 Aug 1;104(1):11-23.
Synthetic recombinant vaccine induces anti-influenza long-term immunity and cross-strain protection.
Arnon R, Levi R. Adv Exp Med Biol. 1996;397:23-9.
Design of peptide and polypeptide vaccines.
Ben-Yedidia T, Arnon R. Curr Opin Biotechnol. 1997 Aug;8(4):442-8.
|
|
|
